跳至主要内容
临床试验/KCT0003386
KCT0003386终止未知

The Effects of Poloxamer and Sodium Alginate Mixture (Guardix-SG®) on Range of Motion after Axillary Lymph Node Dissection: A single-center, prospective, randomized, controlled trial

Asan Medical Center0 个研究点目标入组 192 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
终止
入组人数
192

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 o Limit(—)
性别
Female

入选标准

  • 1. Adults over 20 years old
  • 2. Patients diagnosed with breast cancer
  • 3. Patients with breast cancer who underwent modified radical mastectomy or breast conserving surgery and performed axillary lymph node dissection
  • (Including patients who underwent preoperative chemotherapy and those who underwent axillary lymph node dissection during surgery)

排除标准

  • 1. Stage 0
  • 2. Stage IV
  • 3. Patients undergoing sentinel node biopsy alone
  • 4. Reconstruction Patient
  • 5. Pre-operative other shoulder disease with shoulder disability
  • 6. Previous history of ipsilateral breast or axilla
  • 7. Patients who are pregnant or lactating

研究者

相似试验